Aarkstore Enterprise-Generics in the Antivirals Market to 2018 - Launch || Aarkstore.com

Document Sample
Aarkstore Enterprise-Generics in the Antivirals Market to 2018 - Launch || Aarkstore.com Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Generics in the Antivirals Market to 2018 - Launch of Generic
Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will
Drive Volume Growth


http://www.aarkstore.com/reports/Generics-in-the-Antivirals-Market-to-
2018-Launch-of-Generic-Combivir-and-Patent-Expiry-of-Sustiva-Kaletra-and-
Epivir-HBV-will-Drive-Volume-Growth-214051.html




RSS Link of GBI Research




Summary

 Company in its present report ”Generics in the Antivirals Market to 2018 - Launch
of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive
Volume Growth” describes generic market in antiviral therapeutics. This report
covers antiviral therapeutics including HIV therapeutics, Hepatitis therapeutics,
Herpes therapeutics, CMV therapeutics and Influenza therapeutics. Generics in
antiviral market are forecast to grow at a CAGR of 10.5% during 2010-2018, largely
due to series of patent expiries in the antiviral market. In 2010 generic HIV/AIDS
therapeutic market sales contributes 46% market share in the total generic antiviral
therapeutic market followed by generic herpes therapeutic market with 39.6% of
market share. It is estimated that in 2010, generics accounted for 18.9% of market
share in global antivirals market, and this market share is forecast to grow and
reach 29.2% by 2018.

Scope
 - Data and analysis on the global generics in antivirals market
 - Market forecasts for the global generics in antivirals market until 2018
 - Market Data on geographical landscape including country wise coverage, cost of
therapy, market size and market share.
 - Key drivers and restraints that have created significant impact on the market.

Table of contents:

1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
3 Generics in Antivirals Market to 2018 - Market Overview 12
3.1 Introduction 12
3.2 Generic in Antivirals Market, Global Revenues 14
3.2.1 Revenue 14
3.2.2 Annual Cost of Treatment 18
3.2.3 Treatment Usage Pattern 19
3.2.4 Drivers and Restraints for Generic Antiviral Market 21
4 Generics in Antivirals Market to 2018 - Geographical Landscape 23
4.1 The US 23
4.1.1 Revenue 23
4.1.2 Treatment Usage Pattern 24
4.2 Top Five Countries of Europe 26
4.2.1 Revenue 26
4.2.2 Treatment Usage Pattern 29
4.3 Japan 31
4.3.1 Revenue 31
4.3.2 Treatment Usage Pattern 32
5 Generics in Antiviral Market to 2018 - Therapeutic Landscape 34
5.1 Global Generic HIV Therapeutics Market 34
5.1.1 Introduction 34
5.1.2 Revenue 35
5.1.3 Annual Cost of Treatment 40
5.1.4 Treatment Flow Algorithm 41
5.1.5 Treatment Usage Pattern 42

List of Figures
List of Tables are also include.



For more related Reports Plz follow The link:


Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign
Direct Investment in Indonesia and Extensive Insurance Coverage in the Philippines
Attract Foreign Pharma Companies

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent
Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms
and Low Cost Manufacturing Put India and China at a Strategic Advantage in
Biosimilar Production

Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to
Limit Drug Counterfeits

Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of
New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process

Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to
Decline in the Absence of New Product Launches and Increased Generic Erosion for
Zemplar, Hectorol and Sensipar

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but
Improving Patient Involvement Remains a Challenge

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures,
Close Regulatory Surveillance and High Compliance Standards
Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:12
posted:7/3/2012
language:
pages:4
Description: It is estimated that in 2010, generics accounted for 18.9% of market share in global antivirals market, and this market share is forecast to grow and reach 29.2% by 2018.